← All stocks

PMV Pharmaceuticals, Inc.

PMVP Net selling

CIK 0001699382 #4532 in the set updated 21 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$1.52M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$1.52M

1 of 1 sales

Net

−$1.52M

−$1.52M against sales at will

By person

5 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

ORBIMED ADVISORS LLC entity

10% owner

—

$1.52M (1)

−$1.52M

4,975,291

9.31%

$7.56M

−23.2%

Mack David Henry

President and CEO

—

451,109

0.8439%

$685.69K

+151.4%

Ticktin Robert

General Counsel & COO

—

98,695

0.1846%

$150.02K

−19.0%

Jalota Deepika

Chief Development Officer

—

89,959

0.1683%

$136.74K

−26.9%

Carulli Michael

Chief Financial Officer

—

60,146

0.1125%

$91.42K

−32.0%

Individual transactions

Insider

Date

Role

Action

Price

Amount

ORBIMED ADVISORS LLC

23 Oct 2025

10% owner

Sell indirect

1,000,000

$1.52

$1.52M

Show all 2 transactions →

What was left out

Form 4 filings counted 11

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 1

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 1

Transactions with no price 0

Shares from compensation/vesting 220,643

History held since 29 Sep 2020